Aortic Valvular Interstitial Cells Apoptosis and Calcification Are Mediated by TNF-related Apoptosis-inducing Ligand
Overview
Authors
Affiliations
Background/objectives: Calcific aortic valvular disease (CAVD) is an actively regulated process characterized by the activation of specific osteogenic signaling pathways and apoptosis. We evaluated the involvement in CAVD of the TNF-related apoptosis-inducing ligand (TRAIL), an apoptotic molecule which induces apoptosis by interacting with the death receptor (DR)-4 and DR5, and whose activity is modulated by the decoy receptor (DcR)-1 and DcR2.
Methods: Sections of calcific and normal aortic valves, obtained at surgery time, were subjected to immunohistochemistry and confocal microscopy for TRAIL immunostaining. Valvular interstitial cells (VICs) isolated from calcific (C-VICs) and normal (N-VICs) aortic valves were investigated for the gene and protein expression of TRAIL receptors. Cell viability was assayed by MTT. Von Kossa staining was performed to verify C-VIC ability to produce mineralized nodules. TRAIL serum levels were detected by ELISA.
Results: Higher levels of TRAIL were detected in calcific aortic valves and in sera from the same patients respect to controls. C-VICs express significantly higher mRNA and protein levels of DR4, DR5, DcR1, DcR2 and Runx2 compared to N-VICs. C-VICs and N-VICs, cultured in osteogenic medium, express significantly higher mRNA levels of DR4, Runx2 and Osteocalcin compared to baseline. C-VICs and N-VICs were sensitive to TRAIL-apoptotic effect at baseline and after osteogenic differentiation, as demonstrated by MTT assay and caspase-3 activation. TRAIL enhanced mineralized matrix nodule synthesis by C-VICs cultured in osteogenic medium.
Conclusions: TRAIL is characteristically present within calcific aortic valves, and mediates the calcification of aortic valve interstitial cells in culture through mechanism involving apoptosis.
Felix Velez N, Tu K, Guo P, Reeves R, Aguado B J Biomed Mater Res A. 2025; 113(3):e37885.
PMID: 39995146 PMC: 11875511. DOI: 10.1002/jbm.a.37885.
Wei K, Cao Y, Kong X, Liu C, Gu X J Inflamm Res. 2024; 17:6485-6500.
PMID: 39310903 PMC: 11416122. DOI: 10.2147/JIR.S462546.
Yang X, Zeng J, Xie K, Su S, Guo Y, Zhang H Mol Med. 2024; 30(1):76.
PMID: 38840067 PMC: 11155186. DOI: 10.1186/s10020-024-00833-8.
Brodeur A, Roy V, Touzel-Deschenes L, Bianco S, Droit A, Fradette J Int J Mol Sci. 2024; 25(4).
PMID: 38396969 PMC: 10889332. DOI: 10.3390/ijms25042291.
Coutts C, Baldwin A, Jebeli M, Jolin G, Mungai R, Billiar K Cells. 2024; 13(1).
PMID: 38201249 PMC: 10778193. DOI: 10.3390/cells13010045.